Literature DB >> 26687129

Stem cell death and survival in heart regeneration and repair.

Eltyeb Abdelwahid1, Audrone Kalvelyte2, Aurimas Stulpinas2, Katherine Athayde Teixeira de Carvalho3, Luiz Cesar Guarita-Souza4, Gabor Foldes5.   

Abstract

Cardiovascular diseases are major causes of mortality and morbidity. Cardiomyocyte apoptosis disrupts cardiac function and leads to cardiac decompensation and terminal heart failure. Delineating the regulatory signaling pathways that orchestrate cell survival in the heart has significant therapeutic implications. Cardiac tissue has limited capacity to regenerate and repair. Stem cell therapy is a successful approach for repairing and regenerating ischemic cardiac tissue; however, transplanted cells display very high death percentage, a problem that affects success of tissue regeneration. Stem cells display multipotency or pluripotency and undergo self-renewal, however these events are negatively influenced by upregulation of cell death machinery that induces the significant decrease in survival and differentiation signals upon cardiovascular injury. While efforts to identify cell types and molecular pathways that promote cardiac tissue regeneration have been productive, studies that focus on blocking the extensive cell death after transplantation are limited. The control of cell death includes multiple networks rather than one crucial pathway, which underlies the challenge of identifying the interaction between various cellular and biochemical components. This review is aimed at exploiting the molecular mechanisms by which stem cells resist death signals to develop into mature and healthy cardiac cells. Specifically, we focus on a number of factors that control death and survival of stem cells upon transplantation and ultimately affect cardiac regeneration. We also discuss potential survival enhancing strategies and how they could be meaningful in the design of targeted therapies that improve cardiac function.

Entities:  

Keywords:  Apoptosis; Cell death; Heart; Regeneration; Stem cells; Therapy

Mesh:

Substances:

Year:  2016        PMID: 26687129      PMCID: PMC5200890          DOI: 10.1007/s10495-015-1203-4

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  215 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  Unchain my heart: the scientific foundations of cardiac repair.

Authors:  Stefanie Dimmeler; Andreas M Zeiher; Michael D Schneider
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 3.  "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation.

Authors:  Mark Sussman
Journal:  Trends Cardiovasc Med       Date:  2007-10       Impact factor: 6.677

4.  Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells.

Authors:  Guokai Chen; Zhonggang Hou; Daniel R Gulbranson; James A Thomson
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

5.  Smooth muscle cell transplantation into myocardial scar tissue improves heart function.

Authors:  R K Li; Z Q Jia; R D Weisel; F Merante; D A Mickle
Journal:  J Mol Cell Cardiol       Date:  1999-03       Impact factor: 5.000

6.  Role of HIF-1alpha and VEGF in human mesenchymal stem cell proliferation by 17beta-estradiol: involvement of PKC, PI3K/Akt, and MAPKs.

Authors:  Seung Pil Yun; Min Yong Lee; Jung Min Ryu; Chang Hun Song; Ho Jae Han
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-05       Impact factor: 4.249

7.  Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43.

Authors:  Gang Lu; Husnain K Haider; Shujia Jiang; Muhammad Ashraf
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

8.  Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle.

Authors:  Jin Hur; Chang-Hwan Yoon; Choon-Soo Lee; Tae-Youn Kim; Il-Young Oh; Kyung-Woo Park; Ji-Hyun Kim; Hyun-Sook Lee; Hyun-Jae Kang; In-Ho Chae; Byung-Hee Oh; Young-Bae Park; Hyo-Soo Kim
Journal:  Stem Cells       Date:  2007-04-05       Impact factor: 6.277

Review 9.  Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells.

Authors:  Li Li; Steffany A L Bennett; Lisheng Wang
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

10.  Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation.

Authors:  Stefano Di Santo; Zijiang Yang; Moritz Wyler von Ballmoos; Jan Voelzmann; Nicolas Diehm; Iris Baumgartner; Christoph Kalka
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

View more
  37 in total

1.  Electrically Conductive Scaffold to Modulate and Deliver Stem Cells.

Authors:  Byeongtaek Oh; Alexa Levinson; Vivek Lam; Shang Song; Paul George
Journal:  J Vis Exp       Date:  2018-04-13       Impact factor: 1.355

Review 2.  Cardiovascular Regenerative Technologies: Update and Future Outlook.

Authors:  Anna Mallone; Benedikt Weber; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-21       Impact factor: 3.747

3.  Commentary: Alas, we are not yet zebrafish.

Authors:  Christopher T Ryan; Todd K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  2020-01-07       Impact factor: 5.209

4.  Cortical bone stem cell-derived exosomes' therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.

Authors:  Giana J Schena; Emma K Murray; Alycia N Hildebrand; Alaina L Headrick; Yijun Yang; Keith A Koch; Hajime Kubo; Deborah Eaton; Jaslyn Johnson; Remus Berretta; Sadia Mohsin; Raj Kishore; Timothy A McKinsey; John W Elrod; Steven R Houser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-08       Impact factor: 4.733

Review 5.  Harnessing the Therapeutic Potential of Extracellular Vesicles for Biomedical Applications Using Multifunctional Magnetic Nanomaterials.

Authors:  Letao Yang; Kapil D Patel; Christopher Rathnam; Ramar Thangam; Yannan Hou; Heemin Kang; Ki-Bum Lee
Journal:  Small       Date:  2022-02-08       Impact factor: 15.153

6.  Physiological and hypoxic oxygen concentration differentially regulates human c-Kit+ cardiac stem cell proliferation and migration.

Authors:  Michael A Bellio; Claudia O Rodrigues; Ana Marie Landin; Konstantinos E Hatzistergos; Jeffim Kuznetsov; Victoria Florea; Krystalenia Valasaki; Aisha Khan; Joshua M Hare; Ivonne Hernandez Schulman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

7.  Endoplasmic reticulum (ER) stress triggers Hax1-dependent mitochondrial apoptotic events in cardiac cells.

Authors:  Eltyeb Abdelwahid; Haijie Li; Jianxin Wu; Ana Carolina Irioda; Katherine Athayde Teixeira de Carvalho; Xuelai Luo
Journal:  Apoptosis       Date:  2016-11       Impact factor: 4.677

8.  Photo-Polymerization Damage Protection by Hydrogen Sulfide Donors for 3D-Cell Culture Systems Optimization.

Authors:  Silvia Buonvino; Matteo Ciocci; Dror Seliktar; Sonia Melino
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

Review 9.  Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy.

Authors:  Jessika Iwanski; Raymond K Wong; Douglas F Larson; Alice S Ferng; Raymond B Runyan; Steven Goldstein; Zain Khalpey
Journal:  Springerplus       Date:  2016-06-16

10.  Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation.

Authors:  Dong Han; Xiang Li; Wen-Si Fan; Jiang-Wei Chen; Tian-Tian Gou; Tao Su; Miao-Miao Fan; Meng-Qi Xu; Ya-Bin Wang; Sai Ma; Ya Qiu; Feng Cao
Journal:  Oncotarget       Date:  2017-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.